Prograf Liver Transplant Medicine

People who have had a heart, kidney, or liver transplant may benefit from a prescription medicine called Prograf® (tacrolimus). This drug is used to help prevent the body from rejecting a newly transplanted organ. Transplant rejection occurs when the immune system recognizes a newly transplanted organ as foreign matter and attacks it. Transplant rejection can cause a transplanted organ to fail.
Prograf is a type of immunosuppressant and works to suppress the immune system by making it less active. As a result, the body is less likely to attack a transplanted organ.
Prograf is approved for the prevention of liver transplant rejection in children. It is not approved for use in children who have received a heart or kidney transplant.
(For more details on this kidney, heart, and liver transplant medicine, click Prograf Uses. This Web page offers a closer look at how this medicine works to prevent organ rejection, and also lists some of Prograf's unapproved uses.)
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.